These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 22448262)
1. Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. Aimola P; Carmignani M; Volpe AR; Di Benedetto A; Claudio L; Waalkes MP; van Bokhoven A; Tokar EJ; Claudio PP PLoS One; 2012; 7(3):e33647. PubMed ID: 22448262 [TBL] [Abstract][Full Text] [Related]
2. Acquisition of apoptotic resistance in cadmium-transformed human prostate epithelial cells: Bcl-2 overexpression blocks the activation of JNK signal transduction pathway. Qu W; Ke H; Pi J; Broderick D; French JE; Webber MM; Waalkes MP Environ Health Perspect; 2007 Jul; 115(7):1094-100. PubMed ID: 17637928 [TBL] [Abstract][Full Text] [Related]
3. Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line. Lecane PS; Kiviharju TM; Sellers RG; Peehl DM Prostate; 2003 Mar; 54(4):258-67. PubMed ID: 12539224 [TBL] [Abstract][Full Text] [Related]
4. Induction of Plac8 promotes pro-survival function of autophagy in cadmium-induced prostate carcinogenesis. Kolluru V; Pal D; Papu John AMS; Ankem MK; Freedman JH; Damodaran C Cancer Lett; 2017 Nov; 408():121-129. PubMed ID: 28844710 [TBL] [Abstract][Full Text] [Related]
6. MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell lines. Tsao CC; Corn PG Cancer Biol Ther; 2010 Dec; 10(12):1315-25. PubMed ID: 20953142 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion, AMPK activation and induces senescence. Obajimi O; Keen JC; Melera PW Prostate; 2009 Aug; 69(11):1206-21. PubMed ID: 19434633 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells. Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275 [TBL] [Abstract][Full Text] [Related]
9. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335 [TBL] [Abstract][Full Text] [Related]
10. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase. Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331 [TBL] [Abstract][Full Text] [Related]
11. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells. Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor. Tam CW; Cheng AS; Ma RY; Yao KM; Shiu SY Endocrinology; 2006 Nov; 147(11):5023-33. PubMed ID: 16873542 [TBL] [Abstract][Full Text] [Related]
13. Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53. Supiot S; Hill RP; Bristow RG Mol Cancer Ther; 2008 Apr; 7(4):993-9. PubMed ID: 18413812 [TBL] [Abstract][Full Text] [Related]
14. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition. Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507 [TBL] [Abstract][Full Text] [Related]
15. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells. Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687 [TBL] [Abstract][Full Text] [Related]
16. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells. Ringer L; Sirajuddin P; Yenugonda VM; Ghosh A; Divito K; Trabosh V; Patel Y; Brophy A; Grindrod S; Lisanti MP; Rosenthal D; Brown ML; Avantaggiati ML; Rodriguez O; Albanese C Cancer Biol Ther; 2010 Aug; 10(4):320-5. PubMed ID: 20574155 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis. Pal D; Suman S; Kolluru V; Sears S; Das TP; Alatassi H; Ankem MK; Freedman JH; Damodaran C Br J Cancer; 2017 Jun; 117(1):56-64. PubMed ID: 28588318 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins. Stangelberger A; Schally AV; Rick FG; Varga JL; Baker B; Zarandi M; Halmos G Prostate; 2012 Apr; 72(5):555-65. PubMed ID: 21796649 [TBL] [Abstract][Full Text] [Related]
19. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. Pulukuri SM; Rao JS Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979 [TBL] [Abstract][Full Text] [Related]